Fidelity Sound BitesFidelity Sound Bites

Paul Taylor | Wise men say, only fools rush in… to Ozempic

View descriptionShare

Fidelity Sound Bites

Your direct connection to some of Fidelity Australia's leading portfolio managers. Listen in every month as they tell you what’s on their mind when it 
29 clip(s)
Loading playlist

Elvis may have been talking about love, but can’t the same be said for markets? GLP1 drugs like Ozempic’s success in the weight loss arena have disrupted the healthcare sector. Most notably ResMed, whose stock price plummeted on the back of predicted decreased demand. But where there is disruption and volatility, Paul Taylor sees opportunity.

This month Paul talks about why taking an immediate view can cloud investors thinking and where he’s seen this all before.

Got questions for us? Email podcastsaustralia@fil.com

See why we’re an Aussie expert

This episode was recorded 3 October 2023. Read our full disclaimer.

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 2 playlist(s)

  1. Fidelity Sound Bites

    29 clip(s)

  2. Fidelity Sound Bites: Paul Taylor

    10 clip(s)

Fidelity Sound Bites

Your direct connection to some of Fidelity Australia's leading portfolio managers. Listen in every m 
Social links
Follow podcast
Recent clips
Browse 29 clip(s)